Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000910200 on June 13, 2000

J. Biol. Chem., Vol. 275, Issue 37, 28739-28749, September 15, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/37/28739    most recent
M000910200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Toyo-oka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Toyo-oka, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Autocrine Action and Its Underlying Mechanism of Nitric Oxide on Intracellular Ca2+ Homeostasis in Vascular Endothelial Cells*

Jie Chen, Yuepeng WangDagger, Yue Wang, Toshiaki Nakajima, Kuniaki Iwasawa, Hisako Hikiji§, Mie Sunamoto, Dong-Kug Choi**, Yutaka Yoshida||, Yoshiyuki Sakaki**, and Teruhiko Toyo-oka

From the Second Department of Internal Medicine, the § Department of Oral and Maxillofacial Surgery, and the ** Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo 113-0033, Japan, the  Molecular Chemistry Laboratory, Takeda Chemical Industries, Osaka 532-0024, Japan, and the || Department of Pharmacology, Niigata University, Niigata 951-8122, Japan

Received for publication, February 3, 2000, and in revised form, June 6, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The rise in cytosolic Ca2+ concentration (Ca2+i) in vascular endothelial cells (ECs) activates the production and release of nitric oxide (NO). NO modifies Ca2+i homeostasis in many types of nonendothelial cells. However, its effect on endothelial Ca2+i homeostasis at basal and excited states remains unclear. In the present study, to elucidate the effect of NO on basal Ca2+i, inositol 1,4,5-trisphosphate-induced Ca2+i release (IICR) was blocked by expressing an antisense against type-1 inositol 1,4,5-trisphosphate receptors or by microinjecting heparin to individual ECs, and the effects of NO that was released by and diffused from adjacent IICR-intact ECs were recorded. After ATP or bradykinin stimulation, IICR-inhibited ECs showed a marked reduction of basal Ca2+i, which was abolished by NG-monomethyl-L-arginine monoacetate pretreatment. The reduction disappeared in sparsely seeded ECs. Exogenous NO gas mimicked the effect of ATP or bradykinin to reduce basal Ca2+i. Blocking plasma membrane Ca2+-ATPase (PMCA), but not Na+-Ca2+ exchange or sarcoplasmic/endoplasmic reticulum Ca2+-ATPase, suppressed the reduction, indicating that the reduction resulted from a NO-dependent potentiation of PMCA. To elucidate the effect of NO on elevated Ca2+i, ATP-, bradykinin-, or thapsigargin-evoked Ca2+i response in the presence and absence of NO production was compared in adjacent IICR-intact ECs. NO was found to potentiate PMCA, which, in turn, greatly attenuated agonist-evoked Ca2+i elevation. NO also potentiated Ca2+ influx, which markedly increased the sustained phase of Ca2+i elevation and possibly NO production. NO did not affect other Ca2+i-elevating and Ca2+i-sequestrating components. Thus, NO-dependent potentiation of PMCA is crucial for Ca2+i homeostasis over a wide Ca2+i range.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Vascular endothelial cells (ECs)1 play an important role in the regulation of blood pressure and local blood flow. ECs respond to physical stimuli and blood-borne chemical signals with the production and release of vasoactive substances that directly affect the tone of vascular smooth muscle cells (VSMCs) (1-4). Cytosolic free Ca2+ concentration (Ca2+i) in ECs plays a crucial role in these processes. For example, Ca2+i elevation activates endothelial nitric-oxide synthase to produce nitric oxide (NO) (5, 6), which is the most potent substance to decrease VSMC tone and proliferation. In ECs, a typical Ca2+i elevation evoked by G-protein-coupled receptor agonists consists of an initial spike and a subsequent sustained phase (7-9). The initial spike mainly originates from inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release (IICR) from the endoplasmic reticulum, and the following sustained phase results from capacitative Ca2+ entry (CCE) across into the plasma membrane (10, 11). In addition to these Ca2+i-elevating parts, Ca2+i is also regulated by Ca2+i-sequestrating components, including Ca2+i uptake by sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) (12, 13), Ca2+i extrusion by plasma membrane Ca2+ ATPase (PMCA) (14-17), and Na+-Ca2+ exchange (NCX) (16-18). Our previous studies have shown that IICR is essential for the induction of CCE in ECs and that CCE plays an important role in the continuous production of NO (7, 8). On the other hand, in a series of nonendothelial cell types, NO has been reported to modify almost all Ca2+i-elevating and Ca2+i-sequestrating components (19, 20). NO attenuates IICR at several steps, by inhibiting G-protein in VSMCs (21) and platelets (22), by inhibiting phospholipase beta  in PC12 cells (23), and by inhibiting IP3 receptors in VSMCs (24). The effects of NO on CCE vary among cell types (19, 20, 25-30); NO potentiates CCE in pancreatic acinar cells (25-27) and colonic epithelial cells (28), does not affect CCE in Jurkat T-lymphocytes (29) and embryonic kidney cells (30), and inhibits CCE in platelets (31) and VSMCs (32). Regarding the effects on Ca2+i sequestration, NO potentiates PMCA (33, 34), NCX (35-37), and SERCA (32) in VSMCs, platelets, and astrocytes. However, in ECs, the effect of NO on Ca2+i homeostasis including Ca2+i-elevating and Ca2+i-sequestrating components remains unclear.

On the other hand, most of the published results so far have been obtained by using exogenous NO. The effects on Ca2+i homeostasis varied among NO donor, NO gas, and endogenous NO, even in the same cell type (19, 20, 34, 38, 39). In the present study, endogenous NO released from bovine aortic ECs was used to clarify its effects on Ca2+i homeostasis by a two-step protocol. First, to observe the effect of NO on basal Ca2+i, IICR response was inhibited in individual ECs by expressing antisense against type 1 IP3 receptor (IP3R1) or by microinjecting heparin. Then the effect of NO that was released by and diffused from adjacent cells on basal Ca2+i of IICR-inhibited ECs was recorded after ATP or bradykinin (BK) stimulation. As a result, NO caused a marked reduction in basal Ca2+i. The reduction was a result of a NO-dependent potentiation of Ca2+i extrusion by PMCA, indicating that this action is crucial for Ca2+i homeostasis at the resting state. Second, to observe the effect of NO on Ca2+i dynamics, ATP- or BK-evoked Ca2+i response in the presence and absence of NO production was compared in adjacent IICR-intact cells. It was found that endogenous NO potentiated PMCA and CCE but did not affect IP3 production, NCX, and SERCA. The potentiation of PMCA greatly attenuated agonist-evoked Ca2+i elevation, while the potentiation of CCE markedly increased the sustained phase of Ca2+i elevation and possibly NO production.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Culture of ECs-- ECs were enzymatically isolated from bovine aorta, cultured, and identified as described previously (8). To avoid fluctuation of results due to differences in cell number and growth cycles, cells that reached confluence were subjected to starvation of fetal bovine serum (1%) for 24 h before experiments. Cells of 4-12 passages were used in this study.

Preparation of Antibodies to Isoforms of IP3 Receptor and Immunoblotting-- Three peptides were synthesized according to the amino acid sequence of the cytosolic C-terminal domain of human type 1 (GHPPHMNVNPQQ(C)), type 2 ((C)LGSNTPHVNHHMPPH), and type 3 ((C)RQRLGFVDVQNCISR) IP3 receptors. All of them were synthesized with an additional cysteine at their N- or C-terminal to facilitate coupling reaction. The sequence for IP3R1 is preserved in most species including mouse and Xenopus (40). The sequences of the corresponding domain in rats are identical except for substitutions of the underlined residues. Antibodies to each of the peptides were purified from rabbit serum by affinity chromatography, and specificities were determined by immunoblotting. After solubilizing the crude homogenate of cultured ECs, SDS-polyacrylamide gel electrophoresis was performed in 6% gel. Samples were then electrotransferred to nitrocellulose membranes using a semidry blotter. Membranes were incubated with antibodies (× 200) against type 1, 2, or 3 IP3 receptor. Subsequently, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies. Antigens recognized by antibodies were detected by enhanced chemiluminescence (Amersham Pharmacia Biotech).

Partial Cloning of Bovine IP3R1 Gene, Construction of Vector, and Transient Transfection of ECs-- Total RNA from cultured bovine aortic ECs was used as a template to generate first stand cDNA using an oligo(dT)18 primer. A two-strand DNA fragment of the bovine IP3R1 gene was amplified by polymerase chain reaction from cDNA using primers (upper, 5'-catcctaacggaacgagctc-3'; lower, 5'-catagcttaaagaggcagtct-3'). The single fragment obtained was inserted into the pCRTMII TA cloning vector (Invitrogen) and sequenced (Hitachi-5500). The fragment spanned 379 bases (-197 to +182) shared 94% homology with human and 93% homology with mouse in the corresponding domain of the IP3R1 gene. The fragment was then subcloned into pEGFPC1 (CLONTECH), and antisense (pG.IP3R1-AS) or sense (pG.IP3R1-S) orientation of the insert was confirmed by sequencing. To reduce the intercellular distance between transfectants and adjacent untransfected cells and to decrease the transfection rate, we used 100% confluent ECs. Transfection was done in a serum-free medium using a mixture of 1.33 µg of pG.IP3R1-AS and 3.3 µl of Lipofectin (Life Technologies, Inc.) per 1.2-mm diameter dish. This method resulted in a low transfection rate of 4-6%. pG.IP3R1-S was used as the control. 12-24 h after transfection, the medium was changed to Dulbecco's modified Eagle's medium with 10% fetal bovine serum. Cells were used for experiments 24 h after the medium was changed.

Buffer Solutions-- HEPES buffer solution, which contained 145 mM NaCl, 5 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2, 10 mM D-glucose, and 10 mM Hepes (pH 7.4), was utilized as the extracellular medium. The Ca2+-free medium consisted of HEPES buffer solution in which CaCl2 was replaced with EGTA (1 mM). To block PMCA, we employed a buffer consisting of 115 mM NaCl, 5 mM KCl, 1 mM CaCl2, 20 mM MgCl2, 10 mM D-glucose, and 10 mM Hepes (pH 8.8) (33). For blockade of NCX, NaCl in the HEPES buffer was totally replaced with 145 mM choline chloride. For blockade of both PMCA and NCX, La3+ (125 µM) was added to the Na+-free HEPES buffer.

Cell Microinjection-- After loading fura-2/AM (4 µM, Molecular Probes, Inc., Eugene, OR) for 40 min, ECs were rinsed and incubated in the Ca2+-free medium. Heparin (Mr = 5000; Wako) dissolved in the vehicle (48 mM K2HPO4, 14 mM Na2HPO4, 4.5 mM KH2PO4, and 400 µM unesterified fura-2, pH 6.9) was injected into the perinuclear cytoplasm (Eppendorf 5171 micromanipulator and 5246 transjector, Hamburg). The injection volume into a cell was controlled by varying heparin concentration and injecting pressure (5-80 mmH2O). Within 5 min after the injection, the medium was changed to HEPES buffer solution containing 1 mM Ca2+ and incubated further for 10 min to stabilize the injected cells.

Measurement of Ca2+i and Mn2+ influx-- ECs were stimulated by ATP, BK, ionomycin (IM), or thapsigargin (TG). All of the four agonists were obtained from Sigma. Ca2+i responses of transfected and untransfected cells as well as heparin-injected and -uninjected cells in the same observation field were individually analyzed by a two-dimensional Ca2+i imaging system, as reported previously (8, 41). The absolute Ca2+i was calculated by comparing the fluorescence ratios at both wavelengths obtained at maximum Ca2+i (achieved by lysing the cells and saturating fura-2 with Ca2+) and minimum Ca2+i (achieved by chelating all free Ca2+ with EGTA) using the following equation: Ca2+i = Kd × (R - Rmin)/(Rmax - R) × Sf2/Sb2. Kd is the dissociation constant (224 nM for fura-2), and Rmin and Rmax are the F340/F380 ratios of the Ca2+-free and Ca2+-bound forms. Sf2/Sb2 is the ratio of the fluorescence values at 380-nm excitation determined at Rmin and Rmax, respectively. Mn2+ (0.5 mM)-induced quenching of fura-2 fluorescence was recorded at the excitation wavelength of 360 nm (F360) for measurement of the cation influx rate. The percentage Mn2+ quenching was obtained from the dynamic F360 divided by the basal F360.

Immunocytostaining-- ECs grown on CELLocate coverslips (Eppendorf) were rinsed with phosphate-buffered saline (pH 7.4) (8) and then fixed in the same buffer plus 3.6% paraformaldehyde. All subsequent steps were performed in Ca2+/Mg2+-free phosphate-buffered saline; cells were washed once for 2 min, permeabilized with 0.5% Triton X-100 for 10 min, and washed three times (5 min/wash). Endogenous peroxidase activity was blocked by MetOH containing 0.3% H2O2 for 10 min. Nonspecific staining was reduced by incubating with 2% skim milk for 15 min before cells were subjected to the antibody against IP3R1 (× 200) in the presence of 10% goat serum for 1 h at room temperature. Then cells were incubated with biotinylated goat anti-rabbit IgG, and peroxidase labeling was carried out with an avidin-biotin complex kit (Vector Laboratories) and visualized by 0.05% 3,3'-diaminobenzidine with 0.01% H2O2 (42).

NO2- Determination and Preparation of NO Gas Solution-- ECs were rinsed, and 0.2 ml of each medium was sampled before and 3 min after the administration of BK (500 nM) or 8 min after the addition of TG (1 µM). The amount of NO2- produced was assayed as NO2-, which was determined by colorimetry after the Griess reaction, as reported previously (8, 43). NO gas solution was prepared according to the method described by Shikano (44). In brief, 50 ml of 50 mM Tris-HCl, pH 7.4, was placed in a rubber-stoppered glass tube (300 ml). The tube was evacuated under vacuum for 20 min at 25 °C and then flushed with O2-free N2 for 20 min on ice; NO gas (99.99%) was flushed through the tube to saturate the atmosphere, and then the tube was vortexed and placed on ice. After 20 min, atmospheric NO was removed by flushing with N2 for 20 min. Saturated NO in buffer (about 3.3 mM) was diluted into degassed buffer and was freshly prepared immediately before use.

Measurement of IP3 Production-- ECs were incubated for 1 h in serum-free HEPES buffer solution and then stimulated with 10 µM ATP or 500 nM BK for 15 and 120 s. Then the medium was removed, and an equal volume of ice-cold 15% (v/v) trichloroacetic acid was added. The lysate was collected and centrifuged for 15 min at 2000 × g at 4 °C. The supernatants were extracted three times with 10 volumes of water-saturated diethyl ether and neutralized to pH 7.5 with NaHCO3. The remaining IP3 was quantified according to the protocol of the IP3 [3H]assay system (Amersham Pharmacia Biotech).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effects of NO on Basal Ca2+i in IICR-inhibited Transfectants-- Immunoblotting revealed that the antibody against IP3R1 reacted with a single 260-kDa band in the crude homogenate of cultured bovine aortic ECs (Fig. 1A). In contrast, neither type 2 nor type 3 IP3 receptor was detected. A pharmacological study of Ca2+i dynamics revealed that ECs responded weakly (Delta Ca2+i rise = 11 nM) to caffeine (3-60 mM), with or without ryanodine pretreatment (10-60 µM; data not shown). These results suggest that IICR mediated by IP3R1, but not Ca2+-induced Ca2+i release, could be the major mechanism involved in Ca2+i release in ECs.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 1.   Subtypes of IP3 receptor expression (A), IP3R1 expression, two-dimensional images of Ca2+i response, and Ca2+i dynamics induced by ATP or BK in transfectants of pG.IP3R1-AS (B) and pG.IP3R1-S (C). A, the crude homogenates of cultured bovine aortic ECs (lanes 1, 3, and 5), A7r5 cells (lanes 2 and 6), and Chinese hamster ovary cells (lane 4) were electrophoresed on 6% SDS-polyacrylamide gel. Each of the two strips was immunoblotted with specific antibodies against type 1 (lanes 1 and 2), 2 (lanes 3 and 4), and 3 (lanes 5 and 6) IP3 receptors. B and C, a-f show transfectants expressing reporter EGFP (a), fura-2-loaded cells (b), two-dimensional images of basal Ca2+i level (c), peak Ca2+i response induced by ATP (10 µM; d), and BK (500 nM; e) in the presence of 1 mM Ca2+ and the immunocytostaining of IP3R1 (f). After wash-out of ATP for 30 min, cells were stimulated by BK. g-h show Ca2+i dynamics in transfectants and adjacent untransfected cells in response to ATP (arrows; g) and BK (arrows; h). Bar, 50 µm.

Of the 4-6% of cells that were successfully transfected with pG.IP3R1-AS, 16% showed reduced IP3R1 expression (data not shown), and 12% showed almost complete inhibition of IP3R1 expression by immunocytostaining (Fig. 1B). On the other hand, the surrounding untransfected cells and cells transfected with pG.IP3R1-S demonstrated normal staining, indicating that the reduction or complete inhibition of IP3R1 expression was a specific effect of pG.IP3R1-AS (Fig. 1, B and C).

Individual transfectants surrounded by untransfected cells were selected to measure Ca2+i handling. Of all of the pG.IP3R1-AS transfectants, about 15 and about 12% demonstrated attenuated and complete inhibition of Ca2+i response to ATP or BK, respectively. The incompletely (data not shown) or completely (Fig. 1B) inhibited Ca2+i response is consistent with immunocytostaining results. Ca2+i dynamics in cells with incomplete IICR inhibition exhibited a delayed and shortened initial Ca2+i spike, with subsequent Ca2+i reduction below the basal level after ATP (Delta Ca2+i = 74 ± 5 nM, Fig. 2A) or BK (Delta Ca2+i = 70 ± 7 nM) stimulation. Ca2+i dynamics in cells with complete IICR inhibition demonstrated not only no initial Ca2+i spike but also marked Ca2+i reduction immediately after ATP (Delta Ca2+i = 84 ± 5 nM; Figs. 1B and 2C) or BK (Delta Ca2+i = 73 ± 4 nM; Fig. 1B) stimulation. After a wash-out of the first ATP solution followed by a 30-min equilibration period, these Ca2+i reductions were reproducible by secondary ATP stimulation (Fig. 2, A and C). On the other hand, in pG.IP3R1-S transfectants, ATP and BK induced a normal Ca2+i response (Fig. 1C).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   ATP-induced Ca2+i dynamics in pG.IP3R1-AS transfectants in the presence of 1 mM Ca2+. Shown are ATP (10 µM)-induced Ca2+i dynamics in cells with incomplete (A and B) and complete (C and D) IICR inhibition with (B and D) and without (A and C) pretreatment with L-NMMA (1 mM) for 30 min between two ATP applications (1st and 2nd, arrows). L-NMMA was added to the medium throughout ATP stimulation (n = 5-6).

Our previous study has shown that NO is produced upon stimulation with ATP or BK, and ATP-induced NO production is reproducible and can be blocked by L-NMMA in bovine aortic ECs (8). Therefore, Ca2+i reduction with or without NO production was compared in the same cell. Cells that exhibited marked Ca2+i reduction after the first ATP stimulation were pretreated with L-NMMA (1 mM; Calbiochem) for 30 min. This procedure dramatically attenuated Ca2+i reduction (Delta Ca2+i = 16 ± 4 nM) at the second ATP stimulation (Figs. 2, B and D), suggesting that Ca2+i reduction was caused by endogenous NO. However, Ca2+i reduction was unchanged by pretreatment with indomethacin (25 µM) for 30 min (data not shown).

Effects of NO on Basal Ca2+i in IICR-inhibited ECs by Microinjection of Heparin-- Since IICR inhibition induced by pG.IP3R1-AS is a relatively slow process, the effects of NO were further investigated in ECs where IICR was directly inhibited by heparin. As shown in Fig. 3, cell 1, injected with 50 mg/ml of heparin at 10 mm H2O, exhibited an incomplete inhibition of the initial Ca2+i spike, with a subsequent Ca2+i reduction below the basal level in response to ATP stimulation. Cell 2 and cell 3, injected with 200 mg/ml of heparin at 20 mm H2O, exhibited a complete inhibition of the initial Ca2+i spike and, moreover, marked Ca2+i reduction (Delta Ca2+i = 103 ± 4 nM), similar to that occurring in pG.IP3R1-AS transfectants. The reduction of Ca2+i in cells with complete IICR inhibition was reproducible in the second ATP stimulation (Delta Ca2+i = 102 ± 4 nM, Fig. 3, B and D). BK also induced Ca2+i reduction in IICR-inhibited cells (Delta Ca2+i = 98 ± 4 nM). As shown in Fig. 4A, microinjection of vehicle or heparin (200 mg/ml) had no effect on basal Ca2+i during a 60-min follow up period. Ca2+i reduction was induced only by the application of an agonist, and it was unlikely that the nonspecific effects of heparin were involved in the process. Cells that exhibited complete IICR inhibition after the first ATP stimulation were pretreated with L-NMMA for 30 min. This procedure completely abolished the marked Ca2+i reduction and led to nearly no Ca2+i rise at the second ATP stimulation (Delta Ca2+i = 2 ± 4 nM; Fig. 4B). When heparin was injected into ECs that were plated at a low density, no Ca2+i reduction was observed after ATP (Fig. 4C) stimulation. Furthermore, in sparsely seeded ECs, treatment with NO gas solution (3 µM) induced Ca2+i reduction in cells injected with heparin (Delta Ca2+i = 38 ± 7 nM) as well as the adjacent IICR-intact cells (Delta Ca2+i = 19 ± 5 nM; Fig. 4D). These findings demonstrated that the reduction of basal Ca2+i caused by NO also occurred in heparin-injected cells.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 3.   Two-dimensional images of Ca2+i responses and Ca2+i dynamics induced by ATP in heparin-injected ECs in the presence of 1 mM Ca2+. A, cell position and time-serial two-dimensional images of Ca2+i responses to first ATP (1st ATP, 10 µM) stimulation. Cell 1 (1), injected with 50 mg/ml heparin, showed a delayed and attenuated Ca2+i rise. Cell 2 (2) and cell 3 (3), injected with 200 mg/ml heparin, showed marked Ca2+i reduction. Shown is the localization of ECs and Ca2+i responses at 10, 20, 35, and 90 s after ATP stimulation. B, fura-2-loaded cells and time-serial images of Ca2+i responses to second ATP (2nd ATP; 10 µM) stimulation. Ca2+i rise was partially recovered in cell 1 but remained suppressed in cell 2 and cell 3. Shown are images of fura-2-loaded cells and Ca2+i responses at 5, 10, 35, and 90 s after ATP stimulation. C and D, Ca2+i dynamics of cell 1 and cell 2 after ATP stimulation (arrow), respectively. Ca2+i dynamics of cell 3, which is similar to that of cell 2, is omitted (n = 4). Bar, 50 µm.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Basal Ca2+i level and ATP- and NO gas solution-induced Ca2+i response in confluent or sparse ECs injected with heparin (200 mg/ml). A, in confluent cells, after microinjection (arrow) of vehicle (a; n = 6) or heparin (b; n = 4), basal Ca2+i was monitored for 60 min and compared with that of adjacent uninjected cells (c; n = 16). B, in confluent cells, cell 1 (1), injected with heparin, showed marked Ca2+i reduction after ATP (10 µM) stimulation (b). Following a wash-out of ATP, cells were pretreated with L-NMMA (1 mM) for 30 min. Ca2+i reduction was abolished and recovered to the basal line after the second ATP stimulation (c). a-d exhibit two-dimensional images of fura-2-loaded cells (a), the Ca2+i rise at 25 s after the first (b) and second (c) ATP stimulation, and Ca2+i dynamics (d; n = 4). C, in sparsely seeded ECs, cell 2 (2), injected with heparin, showed no Ca2+i reduction after ATP stimulation. a-c exhibit two-dimensional images of fura-2-loaded cells (a), the Ca2+i rise at 25 s (b) after ATP stimulation, and Ca2+i dynamics (c; n = 2). D, in sparsely seeded ECs, cell 3 (3), injected with heparin, shows Ca2+i reduction after treatment with NO gas solution (3 µM). a-c exhibit two-dimensional images of fura-2-loaded cells (a), the peak reduction of basal Ca2+i at 10 s (b) after treatment with NO, and Ca2+i dynamics (c; n = 3). Bar, 100 µm.

Changes of Ca2+ Influx, Internal Ca2+i Stores, and Ca2+i Extrusion in IICR-inhibited ECs-- The reduction of basal Ca2+i was reversible naturally (Fig. 5, A, a). Mn2+ quenching showed that ATP-induced (Fig. 5A, c) or BK-induced (data not shown) Ca2+ influx was almost absent during the reduction. After removal of the agonist, the reduction was restored relatively rapidly (Fig. 5A, b), during which Ca2+ influx increased mildly (Fig. 5A, c).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Recovery process of Ca2+i reduction (A), ionomycin-releasable Ca2+i stores (B), and Ca2+i reduction after inhibition of SERCA (C). A, in heparin-injected cells, ATP (10 µM)-evoked Ca2+i reduction shows a reversible process, naturally (a) or by ATP removal (w.o.) (b). Coinciding with a and b, c shows changes in Mn2+ (0.5 mM) quenching of IICR-inhibited cells (traces 1 and 2) and adjacent IICR-intact cells (trace 3) with (traces 2 and 3) and without (trace 1) the removal (arrows) of ATP. Note that after removal of ATP, fresh medium contains 0.5 mM Mn2+. B, heparin-injected cells show no difference in Ca2+i release between direct IM application (thin line) and IM application after ATP-induced Ca2+i reduction (thick line, a). In b, each column denotes the mean ± S.E. of Delta Ca2+i reduction (black columns) and Delta Ca2+i rise induced by direct IM application (open columns) and IM application after ATP-induced Ca2+i reduction (stippled columns) in both pG.IP3R1-AS transfectants and heparin-injected cells. C, the transfectants of pG.IP3R1-AS (a, thin line) with complete IICR inhibition and adjacent IICR-intact cells (thick line) were stimulated by ATP at 20 s after the addition of TG (1 µM). Note that there was still an ATP-evoked Ca2+i reduction. Coinciding with a, b denotes changes in Mn2+ quenching after TG-ATP stimulation for IICR-inhibited cells (thin line) and adjacent IICR-intact cells (thick line). c denotes changes in Mn2+ quenching after TG stimulation for IICR-inhibited cells (thin line) and adjacent IICR-intact cells (thick line). NS, no significance; n = 4-7.

Next, the Ca2+i sequestration pathway through which NO reduced basal Ca2+i was examined. First, we investigated whether the reduction of Ca2+i was a result of a NO-dependent potentiation of SERCA. In the absence of Ca2+, ATP- or BK-induced Ca2+i release is caused by IICR, and further Ca2+i release induced by IM represents the residual content of internal Ca2+i stores. In pG.IP3R1-AS transfectants and cells injected with heparin, no significant increase in IM-releasable stores was found in between cells that showed marked Ca2+i reduction after ATP stimulation and cells that were directly stimulated by IM (Fig. 5B). Cells used in the study of direct IM stimulation demonstrated an ATP-induced Ca2+i reduction 30 min prior to IM addition. Furthermore, at 20 s after TG addition, ATP (Fig. 5C, a) or BK (data not shown) still induced a reduction of basal Ca2+i. The reduction, however, is attenuated compared with the case without TG. In IICR-inhibited cells, TG induced Ca2+i elevation in the Ca2+-free medium (data not shown). TG-ATP-induced (Fig. 5C, b) or TG-induced (Fig. 5C, c) Mn2+ quenching increased, compared with ATP-induced quenching (Fig. 5A, c). Thus, the attenuation of Ca2+i reduction might be caused by the counteraction of the reduction by TG-induced Ca2+ leakage from ER and TG-induced Ca2+ influx. These results proved that Ca2+i reduction in IICR-inhibited cells was not caused by SERCA stimulation.

Second, we investigated whether the reduction of basal Ca2+i was a result of NO-dependent Ca2+i extrusion by PMCA (Na+-independent Ca2+i efflux) or NCX (Na+-dependent Ca2+i efflux). Blockade of PMCA by 20 mM extracellular Mg2+ (pH 8.8; Fig. 6A) almost completely abolished the NO-induced Ca2+i reduction (Delta Ca2+i = 82 ± 4 nM; 8 ± 5 nM) in IICR-inhibited cells. Blockade of NCX by replacing extracellular Na+ with choline did not affect the reduction (Delta Ca2+i = 82 ± 4 nM; 80 ± 6 nM; Fig. 6B). Blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+ also eliminated the reduction (Delta Ca2+i = 82 ± 4 nM; 11 ± 6 nM; Fig. 6C). To rule out the possibility that these blockades might decrease NO production in adjacent IICR-intact cells, NO2- production was assayed. Even with the blockade of PMCA and/or NCX, NO was produced during BK stimulation (Fig. 6D). Thus, Ca2+i reduction in IICR-inhibited cells was caused by the NO-dependent potentiation of Ca2+i extrusion by PMCA.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of PMCA or NCX blockade on the Ca2+i reduction in IICR-inhibited cells and NO production from adjacent IICR-intact cells in the presence of 1 mM Ca2+. A, pG.IP3R1-AS transfectants showed Ca2+i reduction upon ATP (10 µM, thick line) stimulation. After wash-out of ATP for 30 min, cells were stimulated by BK (500 nM, thin line) under the blockade of PMCA by 20 mM Mg2+ (pH 8.8). B, pG.IP3R1-AS transfectants showed Ca2+i reduction upon ATP (thick line) stimulation. After wash-out of ATP, cells were stimulated by BK (thin line) under the blockade of NCX by 0 mM Na+. C, under the blockade of NCX by 0 mM Na+, pG.IP3R1-AS transfectants showed Ca2+i reduction upon ATP (thick line) stimulation. After wash-out of ATP, cells were stimulated by BK (thin line) under the blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+. D, effect of PMCA or NCX blockade on BK-induced NO production in IICR-intact cells. Each column denotes the mean ± S.E. *, p < 0.05 between the presence and absence of L-NMMA (1 mM) (n = 4-7).

Effects of NO on Agonist-evoked Ca2+i Elevation in Adjacent IICR-intact ECs-- The effects of NO on agonist-evoked Ca2+i elevation were investigated by comparing Ca2+i response in the presence and absence of NO production. Inhibition of NO production by L-NMMA significantly potentiated the initial spike in the presence and absence of 1 mM Ca2+ (Figs. 7, A and B, and 8, A and B, and Table I). Our previous study has proven that NO is produced in the Ca2+-free medium after ATP or BK stimulation, although the amount produced is less than that produced in the presence of 1 mM Ca2+ (8).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of NO on the sustained phase of Ca2+i dynamics and Ca2+ influx with and without blockade of PMCA or NCX in IICR-intact ECs in the presence of 1 mM Ca2+. The upper panel shows Ca2+i dynamics in response to ATP (10 µM; A) and BK (500 nM; B-D) with (thin solid line) or without (thick solid line) pretreatment with L-NMMA (1 mM). Coinciding with the upper panel, the lower panel shows Ca2+ influx in response to ATP (E) and BK (F-H) with (thin solid line) or without (thick solid line) pretreatment with L-NMMA. Furthermore, in B and F, cells were stimulated under the blockade of PMCA by 20 mM Mg2+ (pH 8.8) with (thin dotted line) or without (thick dotted line) pretreatment with L-NMMA. In C, D, G, and H, cells were stimulated under the blockade of NCX by 0 mM Na+ with (thin dotted line) or without (thick dotted line) pretreatment with L-NMMA. In D and H, cells were stimulated under the blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+ with (thin gray solid line) or without (thick gray solid line) pretreatment with L-NMMA. Mn2+ (0.5 mM) was simultaneously applied to cells with stimuli (arrows) (n = 6-10).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Modification of intracellular Ca2+i dynamics of ECs by NO
Agonist actions were examined in the presence of 1 mM extracellular Ca2+ (Ca2+ (+) or after chelating with 1 mM EGTA without the addition of Ca2+ (Ca2+ (-)). The peak Ca2+i (Peak) and Ca2+i level at 90, 210, or 240 s after the addition of an agonist is expressed in nM. Mn2+ quenching at 210 s (Mn2+-210 s) is expressed as the percentage of change from the basal level. After ATP or BK stimulation in Ca2+ (-), the peak of the residual Ca2+i release induced by ionomycin (Peak-IM) is expressed in nM. Each value indicates the mean ± S.E. (n = 7-14). L-NMMA was applied 30 min prior to stimulation. TG-ATP and TG-BK, cells were treated with TG at 20 s before ATP and BK stimulation, respectively.

First, the mechanism of NO-dependent attenuation of the initial Ca2+i spike was investigated. The effect of NO on ATP- or BK-induced IP3 production was measured by radioimmunoassay. The basal IP3 concentration was 0.7 ± 0.1 µM in ECs. In the Ca2+-free medium, ATP- and BK-induced IP3 concentrations were 2.8 ± 0.3 and 2.9 ± 0.3 at 15 s and 2.7 ± 0.4 and 2.9 ± 0.4 µM at 120 s after stimulation, respectively (n = 4). After L-NMMA pretreatment, ATP- and BK-induced IP3 concentrations were 2.9 ± 0.4 and 3.1 ± 0.3 at 15 s and 2.8 ± 0.4 and 3.0 ± 0.7 µM at 120 s after stimulation, respectively (n = 4). Therefore, IP3 concentration was not significantly changed in cells with and without pretreatment with L-NMMA after both ATP and BK stimulus. This indicates that NO did not inhibit IP3 production in ECs.

Even after the initial Ca2+i spikes were attenuated by NO in the Ca2+-free medium, IM-induced residual Ca2+ release was not significantly changed (Fig. 8, Table I). Furthermore, TG (1 µM) was used at 20 s before treatment with ATP or BK in the Ca2+-free medium. Under the inhibition of SERCA, L-NMMA pretreatment still potentiated the agonist-evoked initial Ca2+i spike (Fig. 9A, Table I), suggesting that NO did not potentiate SERCA.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of NO on initial Ca2+i spike and IM-releasable residual Ca2+i stores in IICR-intact cells in Ca2+-free medium. Shown is the initial Ca2+i spike in response to ATP (10 µM; A) or BK (500 nM; B) and then to ionomycin (1 µM) (n = 4-10).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 9.   Effects of NO on Ca2+i extrusion mediated by PMCA or NCX after blockade of SERCA in IICR-intact cells in Ca2+-free medium. Shown is the initial Ca2+i spike evoked by TG and BK (upper panel) or TG only (lower panel) after blockade of PMCA by 20 mM Mg2+ (pH 8.8; A and D), blockade of NCX by 0 mM Na+ (B and E), and blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+ (C and F). In the upper panel, cells were treated with TG (1 µM) at 20 s before BK (500 nM) stimulation (n = 6-10).

The following studies were addressed to investigate the NO-dependent potentiation of Ca2+i extrusion. In the presence of 1 mM Ca2+, the effect of NO on BK-induced Ca2+ dynamics was observed after the blockade of PMCA or NCX, while the SERCA mechanism remained operational. Blockade of PMCA by 20 mM Mg2+ (pH 8.8) significantly raised BK-induced Ca2+i elevation, decreased Ca2+ influx, and slightly attenuated NO production (Figs. 6D and 7, B and F, and Table I). Under the blockade of PMCA, L-NMMA pretreatment did not markedly influence these effects (Fig. 7, B and F, and Table I). In contrast, blockade of NCX by 0 mM Na+ demonstrated no prominent effect on the initial spike, the sustained phase, and the Ca2+ influx (Figs. 7, C and G). Under the blockade of NCX, L-NMMA pretreatment mildly potentiated Ca2+i elevation. Blockade of both PMCA and NCX by 0 mM Na+ and 125 µM La3+ raised BK-induced Ca2+i elevation, decreased Ca2+ influx, and attenuated NO production (Fig. 7, D and H, Table I). Under the blockade of both PMCA and NCX, L-NMMA pretreatment did not markedly influence these effects. These results indicated that the NO-dependent potentiation of PMCA might be involved in Ca2+i extrusion while Ca2+i is elevated by agonist stimulation.

To prove this hypothesis, we investigated the effect of NO after further inhibition of SERCA by TG (1 µM) at 20 s before BK treatment in the Ca2+-free medium. Blockade of PMCA by 20 mM Mg2+ (pH 8.8) significantly raised the BK-induced initial Ca2+i spike (Fig. 9A, Table I). Under the blockade of PMCA, further inhibition of NO production did not change the potentiation of the BK-induced Ca2+i spike. On the other hand, blockade of NCX showed no significant effect on the BK-induced Ca2+i spike (Fig. 9B, Table I). Under the blockade of NCX by 0 mM Na+, further inhibition of NO production mildly potentiated the BK-induced Ca2+i spike. Blockade of both PMCA and NCX by 0 mM Na+ and 125 µM La3+ markedly raised the Ca2+i spike (Fig. 9C). Under the blockade of both PMCA and NCX, L-NMMA pretreatment did not markedly influence these effects. Similar results were obtained by using TG only, to inhibit SERCA and to stimulate Ca2+i rise and NO production in the Ca2+-free medium (Fig. 9, D-F). NO was produced during TG stimulation even in the presence of PMCA and/or NCX blockade (Fig. 10). These results strongly indicate that the attenuation in the initial Ca2+i spike is caused by the NO-dependent potentiation of PMCA, which plays an important role in attenuating Ca2+i signal in the excited state.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 10.   TG-induced NO production in IICR-intact cells in Ca2+-free medium. Shown is the effect of PMCA or NCX blockade on TG (1 µM)-induced NO production. Each column denotes the mean ± S.E. *, p < 0.05 between the presence and absence of L-NMMA (1 mM). (n = 4-6).

Second, in contrast to attenuating the initial Ca2+i spike, NO significantly increased the sustained Ca2+i phase (Fig. 7, A and B, Table I). As shown by Mn2+ quenching of fluorescence, NO markedly potentiated Ca2+ influx (from 17 ± 3 to 30 ± 3% at 210 s after ATP stimulation, p < 0.05; from 18 ± 3 to 27 ± 4% at 210 s after BK stimulation, p < 0.05; Fig. 7, E and F, and Table I). The potentiated Ca2+ influx coincided with the sustained phase of Ca2+i transients. These results suggest that endogenous NO maintains Ca2+i elevation during the sustained phase by promoting CCE.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The major findings of the present study are as follows. 1) There is marked reduction of basal Ca2+i after ATP or BK stimulation in individual ECs in which IICR and the subsequent CCE are inhibited by expressing an antisense against IP3R1 or microinjecting heparin. 2) The reduction of Ca2+i results from NO that was released by and diffused from adjacent IICR-intact ECs. 3) NO reduces basal Ca2+i by potentiation of Ca2+i extrusion by PMCA. 4) This potentiation also markedly attenuates agonist-evoked Ca2+i elevation in adjacent IICR-intact cells. 5) Endogenous NO markedly promotes agonist-evoked CCE, which maintains Ca2+i elevation and possibly NO production in ECs.

Crucial Role of NO-dependent Potentiation of PMCA in Basal Ca2+i Homeostasis-- NO donor or NO gas has been widely used to mimic the effect of endogenous NO (19, 20). However, their effect on basal Ca2+i has been controversial because of conflicting results. In platelets, Johansson et al. (34) reported that sodium nitroprusside (SNP; 20 µM) reduces basal Ca2+i by 20-23 nM. In contrast, in ECs, Volk et al. (38) reported that SNP (10-1000 µM) significantly increases Ca2+i up to about 200% of the basal level (Delta Ca2+i = 300 nM), similar to the Ca2+i rise induced by 10 µM ATP. Actually, our group also confirmed that 100-300 µM SNP, and not 1-30 µM SNP, mildly increases basal Ca2+i by 10-20 nM in both ECs and VSMCs. However, its nonspecific Ca2+i-raising effect, which is produced by its intermediate or metabolized compounds, could not be excluded from the results, since the Ca2+i rise could not be inhibited by methemoglobin (50 µM).2 In platelets, Sang et al. (39) reported that a high (5 µM) and not a low concentration of NO gas solution (0.1 µM) increases basal Ca2+i by 10 nM.

On the other hand, our previous studies have shown that after ATP stimulation, endogenous NO that is released by and diffused from ECs decreases basal Ca2+i in adjacent VSMCs by about 40-90 nM in the coculture of both cells (8, 41). The results are consistent with the physiological effect of NO on VSMCs. However, a similar analysis of the effect of endogenous NO on basal Ca2+i in ECs is difficult because agonist-evoked Ca2+i elevation is needed for NO production. Although antagonists against receptor (45), G-protein (46), or phospholipase beta  (47) are able to inhibit Ca2+i elevation, they are inadequate for the analysis, since these treatments in a culture dish inhibited Ca2+i elevation in all ECs and consequently led to a decrease in NO production. The effect of NO may only be analyzed in individual ECs in which agonist-evoked Ca2+i elevation is inhibited. In the present study, by using individual ECs in which agonist-evoked Ca2+i elevation was inhibited by the antisense or heparin and by using adjacent excited ECs as a source of NO production, the potent effect of endogenous NO on reducing basal Ca2+i was successfully elucidated. The reduction of basal Ca2+i by endogenous NO has been substantiated, including the partial mimicry by exogenous NO gas. Our studies suggested that endogenous NO is the most ideal source for exploring the physiological effect of NO. NO donor or even NO gas does not always act in the same way as endogenous NO because of difficulty in maintaining the narrow range of effective concentration and mimicking the diffusion pattern of NO in vivo.

The mechanism involved in the reduction of basal Ca2+i was clarified. Our results excluded the involvement of NO-dependent potentiation of SERCA, since there was no consequent increase in IM-releasable Ca2+i stores after the reduction of basal Ca2+i (Fig. 5B), and ATP or BK still induced Ca2+i reduction after SERCA was blocked (Fig. 5C). After blocking SERCA, the attenuation of Ca2+i reduction could be explained by the counteraction by TG-induced Ca2+ leakage from internal stores and TG-induced CCE. The remaining hypothesis is that NO potentiates Ca2+i extrusion by PMCA or NCX. Recently, there is increasing evidence that PMCA is important for Ca2+i extrusion, while NCX plays a minor role (14-18). Thus, the effects of blocking PMCA or NCX on Ca2+i reduction in IICR-inhibited cells were investigated. It was reported that extracellular increase in pH to 8.8 blocks the activity of PMCA in squid axons and red cells, does not alter the activity of NCX and SERCA, and minimally changes intracellular pH (33, 35, 48, 49). Increasing extracellular Mg2+ concentration to 20-30 mM can also block the activity of PMCA in red cells and VSMCs (33, 35, 49). The combination of 20 mM Mg2+ and pH 8.8 blocks PMCA-mediated Ca2+i efflux by up to 80% in VSMCs, whereas it did not affect NCX (33, 35, 50). That PMCA can be blocked by 20 mM Mg2+ (pH 8.8) from the side opposite to the ATP-binding site of the membrane holds true not only for the case in VSMCs but is a general property of the membrane Ca2+ pump ATPase (33, 35, 48-51). Furthermore, extracellular La3+ at concentrations of 60-250 µM specifically blocks PMCA but spares NCX in red cells and VSMCs (IC50 = 50-65 µM; Refs. 33 and 52). Low concentrations of La3+ (20-100 µM) inhibit PMCA activity by displacing Mg2+ from the site at which it combines to accelerate dephosphorylation (53). Therefore, these methods were used to block PMCA of ECs in the present study. On the other hand, NCX was blocked by a Na+-free buffer. The extracellular Na+-free buffer would induce changes in intracellular conditions, which, in turn, could affect the activity of PMCA indirectly. However, a previous study showed that the extracellular Na+-free buffer caused a decrease in intracellular Na+ concentration by 30% in VSMCs (33). Such a decrease in Na+ concentration did not affect the activity of PMCA significantly, since intracellular Na+ and K+ substituted for each other in activating PMCA (54). Several studies have revealed the function of PMCA under the inhibition of NCX using the same method (32, 33, 35, 48-51).

Consequently, Ca2+i reduction was suppressed after the blockade of PMCA but still occurred after the blockade of NCX in IICR-inhibited cells (Fig. 6). These blockades did not significantly affect BK-induced NO production by adjacent IICR-intact cells. Thus, Ca2+i reduction results from the NO-dependent potentiation of Ca2+i extrusion by PMCA, which may be a major and potent regulator of basal Ca2+i homeostasis in ECs. Our results are consistent with previous reports for VSMCs and platelets. In VSMCs, Furukawa et al. (33) reported that SNP or 8-Br-cGMP markedly accelerated the Ca2+i extrusion by PMCA, especially at basal Ca2+i level. In platelets, Johansson et al. (34) reported that both SNP (10 µM) and dibutyryl-cGMP (1 mM) significantly increased Vm of PMCA without affecting its Km or Hill coefficient. SNP or dibutyryl-cGMP, however, did not change the rate of NCX that has a minor contribution to basal Ca2+i extrusion. As a result of potentiation of PMCA, SNP or dibutyryl-cGMP decreased the basal Ca2+i and attenuated the ionomycin-induced Ca2+i elevation. These effects resulted from a cGMP-induced phosphorylation of PMCA (34).

NO Potentiates PMCA as Well as CCE during Agonist Stimulation-- NOdependent potentiation of PMCA is also important for Ca2+i extrusion during the BK- or TG-evoked Ca2+i elevation (Fig. 9). As indicated by its action on the basal Ca2+i (70-150 nM), the TG-evoked Ca2+i elevation (200-260 nM), and the ATP- or BK-evoked Ca2+i elevation (~600 nM), NO-dependent potentiation of PMCA functions to extrude Ca2+i over a wide Ca2+i range. Therefore, the potentiation may be crucial for the normal function of ECs. As regards NCX, our results indicated that it also plays a minor role during agonist-evoked Ca2+i elevation, consistent with the results of previous studies (16, 55, 56).

The present study also showed the significant potentiation of CCE by NO. The lifetime of NO spans only about 6 s (57), suggesting that the potentiation was not due to the NO produced during initial Ca2+i spike but rather to the NO produced during the sustained Ca2+i phase. As shown in Fig. 7, the potentiation is necessary for the maintenance of Ca2+i elevation during the sustained phase, where IICR is decreased and PMCA still functions to decrease Ca2+i. Our group and others have reported the importance of CCE in NO production (7, 8, 58). The mechanism was explained by the ability of endothelial nitric-oxide synthase to be directly activated by Ca2+ influx, based on immunostaining findings that endothelial nitric-oxide synthase is locally linked to caveolin beneath the plasma membrane (5). The potentiation of CCE by endogenous NO may contribute to the continuous NO production during the sustained phase. By summing up these results, we extrapolate that the Ca2+i elevation and continuous NO production during the sustained phase might be maintained by a positive feedback mechanism between NO production and Ca2+ influx. The feedback mechanism explains clearly the continuous NO production during the sustained phase (7, 8, 58).

In conclusion, the present study revealed that endogenous NO modifies Ca2+i signal in ECs by potentiating PMCA and CCE. At the basal state and during the initial Ca2+i spike after agonist stimulation, NO potentiates PMCA, which contributes to keep the basal Ca2+i level low and buffer the rapid Ca2+i rise induced by agonists. During the sustained Ca2+i phase, apart from potentiating PMCA, NO mainly potentiates CCE, which keeps the Ca2+i level elevated and possibly enhances NO production.

    ACKNOWLEDGEMENTS

We are grateful to Dr. Masamitsu Iino (Department of Pharmacology) and Dr. Katsuhiko Mikoshiba (Department of Molecular Neurobiology, Institute of Medical Science) of the University of Tokyo for expert assistance during the course of this study.

    FOOTNOTES

* This work was supported by grants-in-aid from the Ministry of Education, Science and Culture, the Ministry of Health and Welfare of Japan, the Research Foundation for Health Science, the Japanese-Chinese Medical Research Collaboration Foundation, the Research Foundation of the Japan Society for the Promotion of Science, the Kanehara-ichiro Foundation, and the Uehara Memorial Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: The Second Dept. of Internal Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan. Tel.: 81-3-5449-5625; Fax: 81-3-5449-5445; E-mail: srwang-tky@umin.ac.jp.

Published, JBC Papers in Press, June 13, 2000, DOI 10.1074/jbc.M000910200

2 J. Chen, Y. Wang, Y. Wang, T. Nakajima, K. Iwasawa, H. Hikiji, M. Sunamoto, D. K. Choi, Y. Yoshida, Y. Sakaki, and T. Toyo-oka, unpublished data.

    ABBREVIATIONS

The abbreviations used are: EC, endothelial cell; BK, bradykinin; Ca2+i, intracellular Ca2+; CCE, capacitative Ca2+ entry; IICR, inositol 1,4,5-trisphosphate-induced Ca2+i release; IM, ionomycin; IP3, inositol 1,4,5-trisphosphate; IP3R1, type 1 IP3 receptor; L-NMMA, NG-monomethyl-L-arginine monoacetate; NCX, Na+-Ca2+ exchange; NO, nitric oxide; PMCA, plasma membrane Ca2+-ATPase; SERCA, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase; TG, thapsigargin; VSMC, vascular smooth muscle cell.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Vane, J. R., Anggard, E. E., and Botting, R. M. (1990) N. Engl. J. Med. 323, 27-36
2. Furchgott, R. F., and Zawadzi, J. V. (1980) Nature 288, 373-376
3. Palmer, R. Y. J., Ferrige, A. G., and Moncada, S. (1987) Nature 327, 524-526
4. Vanhoutte, P. M., and Shimokawa, H. (1989) Circulation 80, 1-9
5. Forstermann, U., Pollock, J. S., Schmidt, H. H. H. W., Heller, M., and Murad, F. (1993) Proc. Natl. Acad. Sci. U. S. A. 88, 1788-1792
6. Marletta, M. A. (1994) Cell 78, 927-930
7. Luckhoff, A., Pohl, U., Mulsch, A., and Busse, R. (1988) Br. J. Pharmacol. 95, 189-196
8. Wang, Y. P., Shin, W. S., Kawaguchi, H., Inukai, M., Kato, M., Sakamoto, A., Uehara, Y., Miyamoto, M., Shimamoto, N., Korenaga, R., Ando, J., and Toyo-oka, T. (1996) J. Biol. Chem. 271, 5647-5655
9. Wang, Y. P., Chen, J., Shin, W. S., Kawaguchi, H., Inukai, M., and Toyo-oka, T. (1996) Circulation 94, I-713
10. Berridge, M. J. (1993) Nature 361, 315-325
11. Berridge, M. J. (1995) Biochem. J. 312, 1-11
12. Mountian, I., Manolopoulos, V. G., Smedt, H. D., Parys, J. B., Missiaen, L., and Wuytack, F. (1999) Cell Calcium 25, 371-380
13. Morgan, A. J., and Jacob, R. (1998) J. Physiol. (Lond.) 513, 83-101
14. Snitsarev, V. A., and Taylor, C. W. (1999) Cell Calcium 25, 409-417
15. Klishin, A., Sedova, M., and Blatter, L. A. (1998) Am. J. Physiol. 274, C1117-C1128
16. Sedova, M., and Blatter, L. A. (1999) Cell Calcium 25, 333-343
17. Goto, Y., Miura, M., and Iijima, T. (1996) Eur. J. Pharmacol. 314, 185-192
18. Hansen, B. A., Batlle, D. C., and O'Donnell, M. E. (1991) Ann. N. Y. Acad. Sci. 639, 566-569
19. Clementi, E. (1997) Trends. Pharmacol. Sci. 18, 266-269
20. Clementi, E. (1998) Biochem. Pharmacol. 55, 713-718
21. Hirata, M., Kohse, K. P., Chang, C. H., Ikebe, T., and Murad, F. (1990) J. Biol. Chem. 265, 1268-1273
22. Nguyen, B. L., Saitoh, M., and Ware, A. (1991) Am. J. Physiol. 261, H1043-H1052
23. Clementi, E., Vecchio, I., Sciorati, C., and Nistico, G. (1995) Mol. Pharmacol. 47, 517-524
24. Cavallini, L., Coassin, M., Borean, A., and Alexandre, A. (1996) J. Biol. Chem. 271, 5545-5551
25. Xu, X, Star, R. A., Tortoric, G., and Muallem, S. (1994) J. Biol. Chem. 269, 12645-12653
26. Xu, X., Zeng, W., Diaz, J., Lau, K. S., Gukovskaya, A. C., Brown, R. J., Pandol, S. J., and Muallem, S. (1997) Cell Calcium 22, 217-228
27. Gukovskaya, A. C., and Pandol, S. J. (1994) Am. J. Physiol. 266, G350-G356
28. Bischof, G., Brenman, J., Bredt, D. S., and Machen, T. E. (1995) Cell Calcium 17, 250-262
29. Bian, X., Bird, G. S., and Putney, J. W., Jr. (1996) Cell Calcium 19, 351-354
30. Bischof, G., Serwold, T. F., and Machen, T. E. (1997) Cell Calcium 21, 135-142
31. Trepakova, E. S., Cohen, R. A., and Bolotina, V. M. (1999) Cir. Res. 84, 201-209
32. Cohen, R. A., Weisbrod, R. M., Gericke, M., Yaghoubi, M., Bierl, C., and Bolotina, V. M. (1999) Circ. Res. 84, 210-219
33. Furukawa, K., Tawada, Y., and Shigekawa, M. (1988) J. Biol. Chem. 263, 8058-8065
34. Johansson, J. S., and Haynes, D. H. (1992) Biochim. Biophys. Acta 1105, 40-50
35. Furukawa, K., Ohshima, N., Tawada, Y., and Shigekawa, M. (1991) J. Biol. Chem. 266, 12337-12341
36. Takuma, K., Matsuda, T., Hashimoto, H., Kitanaka, J., Asano, S., Kishida, Y., and Baba, A. (1996) J. Neurochem. 67, 1840-1845
37. Asano, S., Matsuda, T., Takuma, K., Kim, H. S., Sato, T., Nishikawa, T., and Baba, A. (1995) J. Neurochem. 64, 2437-2441
38. Volk, T., Mading, K., Hensel, M., and Kox, W. J. (1997) J. Cell. Physiol. 172, 296-305
39. Sang, K. H. L. Q., Lantoine, F., and Devynck, M. A. (1996) Br. J. Pharmacol. 119, 1361-1366
40. Kume, S., Muto, A., Aruga, J., Nakagawa, T., Michikawa, T., Furuichi, T., Nakade, S., Okano, H., and Mikoshiba, K. (1993) Cell 73, 555-570
41. Shin, W. S., Sasaki, T., Kato, M., Hara, K., Seko, A., Yang, W. D., Shimamoto, N., Sugimoto, T., and Toyo-oka, T. (1992) J. Biol. Chem. 267, 20377-20382
42. Kawaguchi, H., Shin, W. S., Wang, Y. P., Inukai, M., Kato, M., Matsuo, Y. O., Sakamoto, A., Uehara, Y., Kaneda, Y., and Toyo-oka, T. (1997) Circulation 95, 2441-2447
43. Yui, Y., Hattoti, R., Kosuga, K., Eizawa, H., Hiki, K., Ohkawa, S., Ohnishi, K., Terao, S., and Kawai, C. (1991) J. Biol. Chem. 266, 3369-3371
44. Shikano, K., Long, C. J., Ohlstein, E. H., and Berkowitz, B. A. (1988) J. Pharmacol. Exp. Ther. 247, 873-881
45. Uneyama, H., Uneyama, C., Ebihara, S., and Akaike, N. (1994) Br. J. Pharmacol. 111, 245-249
46. Xu, X, Zeng, W., and Muallem, S. (1996) J. Biol. Chem. 271, 11737-11744
47. Strobaek, D., Olesen, S. P., Christophersen, P., and Dissing, S. (1996) Br. J. Pharmacol. 118, 1645-1652
48. DiPolo, R., and Beauge, L. (1982) Biochim. Biophys. Acta 688, 237-245
49. Kratje, R. B., Garrahan, P. J., and Rega, A. F. (1985) Biochim. Biophys. Acta 816, 365-378
50. DiPolo, R. (1978) Nature 274, 390-392
51. Wakabayashi, S., Ogurusu, T., and Shigekawa, M. (1987) J. Biol. Chem. 262, 9121-9129
52. Shimizu, H., Borin, M. L., and Blaustein, M. P. (1997) Cell Calcium 21, 31-41
53. Herscher, C. J., and Rega, A. F. (1997) Ann. N. Y. Acad. Sci. 834, 407-409
54. Sarkadi, B., Macintyre, J. D., and Gordos, G. (1978) FEBS Lett. 89, 78-82
55. Schilling, W. P., Ritchie, A. K., Navarro, L. T., and Eskin, S. G. (1988) Am. J. Physiol. 255, H219-H227
56. Laskey, R. E., Adams, D. J., Johns, A., Rubanyi, G. M., and van Breemen, C. (1990) J. Biol. Chem. 265, 2613-2619
57. Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D., and Wishnok, J. S. (1988) Biochemistry 27, 8706-8711
58. Buckley, B. J., Mirza, Z., and Whorton, A. R. (1995) Am. J. Physiol. 269, C757-C765


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. Perrier, M.-P. Fournet-Bourguignon, E. Royere, S. Molez, H. Reure, L. Lesage, W. Gosgnach, Y. Frapart, J.-L. Boucher, N. Villeneuve, et al.
Effect of uncoupling endothelial nitric oxide synthase on calcium homeostasis in aged porcine endothelial cells
Cardiovasc Res, April 1, 2009; 82(1): 133 - 142.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Garcia-Mata, R. Gay, S. Sokolovski, A. Hills, L. Lamattina, and M. R. Blatt
Nitric oxide regulates K+ and Cl- channels in guard cells through a subset of abscisic acid-evoked signaling pathways
PNAS, September 16, 2003; 100(19): 11116 - 11121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Koizumi, H. Hikiji, W. S. Shin, T. Takato, S. Fukuda, T. Abe, N. Koshikiya, K. Iwasawa, and T. Toyo-oka
Cell Density and Growth-dependent Down-regulation of Both Intracellular Calcium Responses to Agonist Stimuli and Expression of Smooth-surfaced Endoplasmic Reticulum in MC3T3-E1 Osteoblast-like Cells
J. Biol. Chem., February 14, 2003; 278(8): 6433 - 6439.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. N Dedkova and L. A Blatter
Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells
J. Physiol., February 15, 2002; 539(1): 77 - 91.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Wang, J. Chen, Y. Wang, C. W. Taylor, Y. Hirata, H. Hagiwara, K. Mikoshiba, T. Toyo-oka, M. Omata, and Y. Sakaki
Crucial Role of Type 1, but Not Type 3, Inositol 1,4,5-Trisphosphate (IP3) Receptors in IP3-Induced Ca2+ Release, Capacitative Ca2+ Entry, and Proliferation of A7r5 Vascular Smooth Muscle Cells
Circ. Res., February 2, 2001; 88(2): 202 - 209.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/37/28739    most recent
M000910200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Toyo-oka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Toyo-oka, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement